ETF Managers Group, LLC Biogen Inc. Transaction History

ETF Managers Group, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Mar 23, 2023	BUY	$252.44 - $306.72 $513,462 - $623,868	2,034 New	2,034 $563,000
Q2 2022 Aug 15, 2022	SELL	$187.54 - $223.02 $465,849 - $553,981	-2,484 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$193.77 - $244.14 $8,719 - $10,986	45 Added 1.85%	2,484 $524,000
Q4 2021 Feb 14, 2022	BUY	$223.92 - $287.77 $25,526 - $32,805	114 Added 4.9%	2,439 $585,000
Q3 2021 Nov 15, 2021	BUY	$282.99 - $369.05 $50,372 - $65,690	178 Added 8.29%	2,325 $664,000
Q2 2021 Aug 16, 2021	BUY	$259.0 - $414.71 $556,073 - $890,382	2,147 New	2,147 $742,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of ETF Managers Group, LLC, based on Form 13F filings with the SEC.

Stay updated on ETF Managers Group, LLC with notifications on news.